Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2020-03-30 Annual Report
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
2019年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2019 Annual Report Summary" of 南微医学科技股份有限公司 (Micro-Tech Medical). It contains detailed financial data for the year 2019, including revenue, net profit, assets, and quarterly breakdowns. It also includes extensive business descriptions, industry analysis, risk disclosures, shareholder information, and management discussion and analysis sections. The document is over 12,000 characters long, indicating it is a substantive report rather than a brief announcement. The content aligns with a comprehensive yearly report covering company activity and full financial performance. Therefore, this document fits the definition of an Annual Report (10-K). FY 2019
2020-03-30 Chinese
董事会审计委员会2019年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee of 南微医学科技股份有限公司 for the year 2019. It discusses the committee's activities, meetings, evaluations of external auditors, internal audit guidance, review of financial reports, internal control assessments, and related party transactions. The content focuses on audit oversight and the committee's fulfillment of its duties during the fiscal year 2019. It is not a full annual report but a specific report on audit committee activities and audit-related matters. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and related audit committee information. The document length is 2643 characters, which is relatively short but contains substantive audit committee content rather than just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2019
2020-03-30 Chinese
独立董事关于第二届董事会第十六次会议相关事项的独立意见
Regulatory Filings
2020-03-30 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司使用部分超募资金永久补充流动资金之核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from the sponsor institution (Nanjing Securities) regarding the use of part of the over-raised funds by Nanwei Medical Technology Co., Ltd. to permanently supplement working capital. It references regulatory guidelines, approval from the board and supervisory committee, and compliance with relevant securities regulations. The document does not contain financial statements or quarterly/yearly financial results but is a formal audit or verification opinion on a specific financial management matter related to fundraising usage. It is not an annual or interim report, earnings release, or a simple announcement. It fits the definition of an Audit Report / Information (AR) as it is a standalone audit/verification report on the use of funds, including compliance with regulatory requirements and internal controls. FY 2019
2020-03-30 Chinese
关于董事会秘书变更的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the change of the company's board secretary, including the resignation of the previous secretary and the appointment of a new one. It contains no financial data, no report or presentation, and no mention of voting results or legal proceedings. The content clearly relates to management changes at the board level. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this topic, confirming the classification.
2020-03-30 Chinese
关于召开2019年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2019 Annual General Meeting (AGM) of 南微医学科技股份有限公司, including the date, voting methods, agenda items, and procedural details. It includes information about the meeting logistics, voting system, and agenda proposals to be discussed and voted on at the AGM. The document does not contain financial statements or results but is focused on informing shareholders about the AGM and the matters to be voted on. The document length is 3373 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2020-03-30 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.